CTOs on the Move

NextStep Arthropedix

www.nextsteparthropedix.com

 
NextStep Arthropedix is a medical device manufacturer focused on designing, developing, manufacturing, and distributing joint replacement implant and instrument products for hip and knee arthroplasty. This company is at the forefront of designing and manufacturing innovative implants characterized by the advantages of 3D printing technology.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

north mountain medical and rehab

north mountain medical and rehab is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vbm Medical Inc

Vbm Medical Inc is a Noblesville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Miromatrix Medical

The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biological mesh for hernia repair – scientists around the globe are working with the Company’s technology and are taking critical steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. While our biological mesh development program has been conducted internally, our intent is for current and future products to be developed both at Miromatrix and in partnership with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.

Gamma Medica-Ideas (GM-I)

Gamma Medica-Ideas (GM-I), Inc is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vermillion

Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.